Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F R Griffiths

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Histopathology|April 2, 2014
Effective maybe, but is it cost-effective?Murali Varma, David F R Griffiths
Histopathology|January 11, 2016
Retained basal cells in metastatic prostate cancerMurali Varma, Fouad S Alchami, David F R Griffiths
Transplantation|February 18, 2003
The presence of glomerular sclerosis at time zero has a significant impact on function after cadaveric renal transplantationXavier Escofet, Hisham Osman, David F R Griffiths, et al.
Histopathology|January 25, 2011
Glutathione S-transferases as molecular markers of tumour progression and prognosis in renal cell carcinomaLydia Searchfield, Sally A Price, Graham Betton, et al.
Oncogene|August 24, 2005
Apc deficiency predisposes to renal carcinoma in the mouseOwen J Sansom, David F R Griffiths, Karen R Reed, et al.
Journal of Translational Medicine|October 15, 2013
Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined diseaseLee Campbell, Ghaith Al-Jayyoussi, Robert Gutteridge, et al.
Journal of Clinical Pathology|November 1, 2012
Prostate needle biopsy processing: a survey of laboratory practice across EuropeMurali Varma, Daniel M Berney, Ferran Algaba, et al.
Human Molecular Genetics|May 13, 2005
A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinomaCatherine Wilson, Shelley Idziaszczyk, Lee Parry, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Histopathology|April 2, 2014
Effective maybe, but is it cost-effective?Murali Varma, David F R Griffiths
Histopathology|January 11, 2016
Retained basal cells in metastatic prostate cancerMurali Varma, Fouad S Alchami, David F R Griffiths
Transplantation|February 18, 2003
The presence of glomerular sclerosis at time zero has a significant impact on function after cadaveric renal transplantationXavier Escofet, Hisham Osman, David F R Griffiths, et al.
Histopathology|January 25, 2011
Glutathione S-transferases as molecular markers of tumour progression and prognosis in renal cell carcinomaLydia Searchfield, Sally A Price, Graham Betton, et al.
Oncogene|August 24, 2005
Apc deficiency predisposes to renal carcinoma in the mouseOwen J Sansom, David F R Griffiths, Karen R Reed, et al.
Journal of Translational Medicine|October 15, 2013
Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined diseaseLee Campbell, Ghaith Al-Jayyoussi, Robert Gutteridge, et al.
Journal of Clinical Pathology|November 1, 2012
Prostate needle biopsy processing: a survey of laboratory practice across EuropeMurali Varma, Daniel M Berney, Ferran Algaba, et al.
Human Molecular Genetics|May 13, 2005
A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinomaCatherine Wilson, Shelley Idziaszczyk, Lee Parry, et al.
Pageof 1